MXPA03001857A - Composicones medicinales. - Google Patents
Composicones medicinales.Info
- Publication number
- MXPA03001857A MXPA03001857A MXPA03001857A MXPA03001857A MXPA03001857A MX PA03001857 A MXPA03001857 A MX PA03001857A MX PA03001857 A MXPA03001857 A MX PA03001857A MX PA03001857 A MXPA03001857 A MX PA03001857A MX PA03001857 A MXPA03001857 A MX PA03001857A
- Authority
- MX
- Mexico
- Prior art keywords
- medicinal compositions
- medicinal
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000265082 | 2000-09-01 | ||
| PCT/JP2001/007438 WO2002020009A1 (fr) | 2000-09-01 | 2001-08-29 | Compositions medicales |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001857A true MXPA03001857A (es) | 2003-06-04 |
Family
ID=18752403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001857A MXPA03001857A (es) | 2000-09-01 | 2001-08-29 | Composicones medicinales. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1314423A4 (es) |
| KR (1) | KR20030029871A (es) |
| CN (1) | CN1473042A (es) |
| AU (2) | AU8254101A (es) |
| BR (1) | BR0113523A (es) |
| CA (1) | CA2420951A1 (es) |
| CZ (1) | CZ2003593A3 (es) |
| HU (1) | HUP0301728A3 (es) |
| IL (1) | IL154414A0 (es) |
| MX (1) | MXPA03001857A (es) |
| NO (1) | NO20030946L (es) |
| NZ (1) | NZ524406A (es) |
| PL (1) | PL362244A1 (es) |
| RU (1) | RU2246302C2 (es) |
| SK (1) | SK2552003A3 (es) |
| WO (1) | WO2002020009A1 (es) |
| ZA (1) | ZA200301543B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002020009A1 (fr) * | 2000-09-01 | 2002-03-14 | Sankyo Company, Limited | Compositions medicales |
| RU2358734C2 (ru) | 2003-08-29 | 2009-06-20 | Кова Ко., Лтд. | Способ стабилизации бляшки с высоким содержанием липидов и способ профилактики ее разрушения |
| TW200619204A (en) * | 2004-12-10 | 2006-06-16 | Kowa Co | Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3720395B2 (ja) * | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | 新規ヘテロ環誘導体、その製造方法およびその医薬用途 |
| WO1997012860A1 (fr) * | 1995-10-05 | 1997-04-10 | Kyoto Pharmaceutical Industries, Ltd. | Nouveaux derives heterocycliques et leur utilisation medicinale |
| EP0858336B1 (en) * | 1995-11-02 | 2006-12-20 | Warner-Lambert Company Llc | Method and pharmaceutical composition for regulating lipid concentration |
| YU23499A (sh) * | 1996-11-27 | 2001-07-10 | Pfizer Inc. | Inhibitorski amidi apo-b-sekrecije/mtp-a |
| JP3333777B2 (ja) * | 1997-10-28 | 2002-10-15 | コリア インスティテュート オブ サイエンス アンド テクノロジー | アシルｃｏａ−コレステロール−ｏ−アシルトランスフェラーゼ抑制剤、動脈壁上でのマクロファージ−脂質複合体蓄積の抑制剤および肝疾患予防または治療剤としての柑橘類果皮抽出物 |
| AP2001002035A0 (en) * | 1998-07-21 | 2001-03-31 | Warner Lambert Co | Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions. |
| WO2001022962A1 (en) * | 1999-09-30 | 2001-04-05 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
| WO2002020009A1 (fr) * | 2000-09-01 | 2002-03-14 | Sankyo Company, Limited | Compositions medicales |
-
2001
- 2001-08-29 WO PCT/JP2001/007438 patent/WO2002020009A1/ja not_active Application Discontinuation
- 2001-08-29 BR BR0113523-6A patent/BR0113523A/pt not_active IP Right Cessation
- 2001-08-29 AU AU8254101A patent/AU8254101A/xx active Pending
- 2001-08-29 KR KR10-2003-7002861A patent/KR20030029871A/ko not_active Application Discontinuation
- 2001-08-29 EP EP01961177A patent/EP1314423A4/en not_active Withdrawn
- 2001-08-29 SK SK255-2003A patent/SK2552003A3/sk not_active Application Discontinuation
- 2001-08-29 CN CNA018184723A patent/CN1473042A/zh active Pending
- 2001-08-29 RU RU2003105835/15A patent/RU2246302C2/ru not_active IP Right Cessation
- 2001-08-29 NZ NZ524406A patent/NZ524406A/en unknown
- 2001-08-29 MX MXPA03001857A patent/MXPA03001857A/es unknown
- 2001-08-29 CA CA002420951A patent/CA2420951A1/en not_active Abandoned
- 2001-08-29 HU HU0301728A patent/HUP0301728A3/hu unknown
- 2001-08-29 IL IL15441401A patent/IL154414A0/xx unknown
- 2001-08-29 PL PL01362244A patent/PL362244A1/xx unknown
- 2001-08-29 CZ CZ2003593A patent/CZ2003593A3/cs unknown
- 2001-08-29 AU AU2001282541A patent/AU2001282541B2/en not_active Ceased
-
2003
- 2003-02-25 ZA ZA200301543A patent/ZA200301543B/en unknown
- 2003-02-28 NO NO20030946A patent/NO20030946L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL154414A0 (en) | 2003-09-17 |
| CN1473042A (zh) | 2004-02-04 |
| SK2552003A3 (en) | 2003-08-05 |
| EP1314423A4 (en) | 2004-05-19 |
| NZ524406A (en) | 2004-06-25 |
| ZA200301543B (en) | 2004-06-09 |
| RU2246302C2 (ru) | 2005-02-20 |
| AU8254101A (en) | 2002-03-22 |
| KR20030029871A (ko) | 2003-04-16 |
| CZ2003593A3 (cs) | 2003-05-14 |
| HUP0301728A3 (en) | 2004-05-28 |
| BR0113523A (pt) | 2004-06-29 |
| HUP0301728A2 (hu) | 2003-08-28 |
| PL362244A1 (en) | 2004-10-18 |
| NO20030946L (no) | 2003-04-08 |
| WO2002020009A1 (fr) | 2002-03-14 |
| AU2001282541B2 (en) | 2004-06-24 |
| CA2420951A1 (en) | 2003-02-28 |
| EP1314423A1 (en) | 2003-05-28 |
| NO20030946D0 (no) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITTO20000779A0 (it) | Composizioni farmaceutiche. | |
| AR028204A1 (es) | Composiciones farmaceuticas electrohiladas | |
| ITTO20010005A0 (it) | Formulazione farmaceutica. | |
| ITMI20010748A0 (it) | Composizioni farmaceutiche | |
| DK1524266T3 (da) | Farmaceutisk sammensætning | |
| ATE303787T1 (de) | Schergelzusammensetzungen | |
| NO20025450L (no) | Ny farmasöytisk sammensetning | |
| IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
| AR028197A1 (es) | Composiciones antitranspirantes | |
| FI20000004A0 (fi) | Flavonoidilääke... | |
| MXPA03001425A (es) | Compuestos farmaceuticos. | |
| NO20026123L (no) | Farmasöytiske sammensetninger | |
| ATE369830T1 (de) | Schweisshemmende zusammensetzungen | |
| ATE314049T1 (de) | Schweisshemmende zusammensetzungen | |
| NO20031095D0 (no) | Farmasöytiske sammensetninger | |
| DE60116858D1 (de) | Zusammensetzung | |
| CH695519A5 (de) | Sperrstromthyristor. | |
| ATE268116T1 (de) | Mesotrion-formulierungen | |
| MXPA03001857A (es) | Composicones medicinales. | |
| ATE403414T1 (de) | Shampoozusammensetzungen | |
| EE200200689A (et) | Ravimkoostised | |
| IT1319677B1 (it) | Composizione funghicida. | |
| ZA200303911B (en) | Medicinal compositions. | |
| IDP000026013A (id) | Komposisi biolakto-aktif | |
| IT1316979B1 (it) | Grigliatrice. |